Neuroendocrinology of the skin

被引:635
作者
Slominski, A
Wortsman, J
机构
[1] Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA
[2] So Illinois Univ, Dept Med, Springfield, IL USA
关键词
D O I
10.1210/er.21.5.457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The classical observations of the skin as a target for melanotropins have been complemented by the discovery of their actual production at the local level. In fact, all of the elements controlling the activity of the hypothalamus-pituitary-adrenal axis are expressed in the skin including CRH, urocortin, and POMC, with its products ACTH, a-MSH, and P-endorphin. Demonstration of the corresponding receptors in the same cells suggests para- or autocrine mechanisms of action. These findings, together with the demonstration of cutaneous production of numerous other hormones including vitamin D-3, PTH-related protein (PTHrP), catecholamines, and acetylcholine that share regulation by environmental stressors such as UV light, underlie a role for these agents in the skin response to stress. The endocrine mediators with their receptors are organized into dermal and epidermal units that allow precise control of their activity in a field-restricted manner. The skin neuroendocrine system communicates with itself and with the systemic level through humoral and neural pathways to induce vascular, immune, or pigmentary changes, to directly buffer noxious agents or neutralize the elicited local reactions. Therefore, we suggest that the skin neuroendocrine system acts by preserving and maintaining the skin structural and functional integrity and, by inference, systemic homeostasis.
引用
收藏
页码:457 / 487
页数:31
相关论文
共 363 条
[81]   CLONING AND FUNCTIONAL EXPRESSION OF A THYROTROPIN RECEPTOR CDNA FROM RAT FAT-CELLS [J].
ENDO, T ;
OHTA, K ;
HARAGUCHI, K ;
ONAYA, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10833-10837
[82]   Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin [J].
Ermak, G ;
Slominski, A .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (02) :160-165
[83]  
Fantini F, 1995, Exp Dermatol, V4, P365, DOI 10.1111/j.1600-0625.1995.tb00061.x
[84]   EXPRESSION OF GROWTH-ASSOCIATED PROTEIN-43 AND NERVE GROWTH-FACTOR RECEPTOR IN HUMAN SKIN - A COMPARATIVE IMMUNOHISTOCHEMICAL INVESTIGATION [J].
FANTINI, F ;
JOHANSSON, O .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :734-742
[85]  
Farrerons J, 1998, BRIT J DERMATOL, V139, P422
[86]   Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells [J].
Fazal, N ;
Slominski, A ;
Choudhry, MA ;
Wei, ET ;
Sayeed, MM .
FEBS LETTERS, 1998, 435 (2-3) :187-190
[87]  
FEICHRATH J, 1999, AM J PATHOL, V155, P583
[88]  
FELING P, 1995, ENDOCRINOLOGY METABO
[89]  
Fitzpatrick TB., 1993, Dermatology in general medicine, V4th
[90]   Corticotropin releasing factor modulates interleukin-1-induced prostaglandin synthesis in fibroblasts: receptor binding and effects of antagonists [J].
Fleisher-Berkovich, S ;
Rimon, G ;
Danon, A .
REGULATORY PEPTIDES, 1998, 77 (1-3) :121-126